Screening for Preeclampsia US preventive services task force recommendation statement

JAMA - Journal of the American Medical Association

Volumn 317, Issue 16, 2017, Pages 1661-1667

  Bibbins Domingo, Kirsten ^a   Grossman, David C ^b   Curry, Susan J ^c   Barry, Michael J ^d   Davidson, Karina W ^e   Doubeni, Chyke A ^f   Epling, John W ^g   Kemper, Alex R ^h   Krist, Alex H ^i,j   Kurth, Ann E ^k   Landefeld, C Seth ^l   Mangione, Carol M ^m   Phillips, William R ⁿ   Phipps, Maureen G ^o   Silverstein, Michael ^p   Simon, Melissa A ^q   Tseng, Chien Wen ^r,s  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KAISER PERMANENTE   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e Columbia University ^*  (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g VIRGINIA TECH CARILION SCHOOL OF MEDICINE   (United States)

^h DUKE UNIVERSITY   (United States)

ⁱ Fairfax Family Practice Residency   (United States)

^j VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^k YALE UNIVERSITY   (United States)

^l UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^m UNIVERSITY OF CALIFORNIA   (United States)

ⁿ UNIVERSITY OF WASHINGTON   (United States)

^o BROWN UNIVERSITY   (United States)

^p BOSTON UNIVERSITY   (United States)

^q NORTHWESTERN UNIVERSITY   (United States)

^r UNIVERSITY OF HAWAII   (United States)

^s PACIFIC HEALTH RESEARCH AND EDUCATION INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; MAGNESIUM SULFATE;

ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL EFFECTIVENESS; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; EARLY INTERVENTION; EVIDENCE BASED MEDICINE; GESTATION PERIOD; HUMAN; MATERNAL MORBIDITY; MATERNAL MORTALITY; MEDICAL RESEARCH; PERINATAL MORBIDITY; PERINATAL MORTALITY; PRACTICE GUIDELINE; PREDICTION; PREECLAMPSIA; PREGNANT WOMAN; PREVENTIVE HEALTH SERVICE; RISK BENEFIT ANALYSIS; RISK REDUCTION; UNITED STATES; ADULT; ADVISORY COMMITTEE; AFRICAN AMERICAN; BLOOD PRESSURE; ETHNOLOGY; FEMALE; MASS SCREENING; MIDDLE AGED; NEWBORN; PRE-ECLAMPSIA; PREGNANCY; PRENATAL CARE; RISK FACTOR; STANDARDS; YOUNG ADULT;

ADULT; ADVISORY COMMITTEES; AFRICAN AMERICANS; BLOOD PRESSURE; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; INFANT, NEWBORN; MASS SCREENING; MIDDLE AGED; PRE-ECLAMPSIA; PREGNANCY; PRENATAL CARE; RISK FACTORS; YOUNG ADULT;

EID: 85018305622     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2017.3439     Document Type: Article

References (32)

1. Ananth CV, Keyes KM, Wapner RJ. Pre-eclampsiarates in the United States, 1980-2010:age-period-cohort analysis. BMJ. 2013;347:f6564.
2. Myatt L, Roberts JM. Preeclampsia: Syndrome ordisease? Curr Hypertens Rep. 2015;17(11):83.
3. Redman C. Pre-eclampsia: A complex and variabledisease. Pregnancy Hypertens. 2014;4(3):241-242.
4. Henderson JT, Thompson JH, Burda BU, CantorA, Beil T, Whitlock EP. Screening for Preeclampsia:A Systematic Evidence Review for the US PreventiveServices Task Force. Evidence Synthesis No. 148. Rockville, MD: Agency for Healthcare Research andQuality; 2017. AHRQ publication 14-05211-EF-1.
5. American College of Obstetricians andGynecologists. Hypertension in Pregnancy. Washington, DC: American College of Obstetriciansand Gynecologists; 2013.
6. Henderson JT, Thompson JH, Burda BU, CantorA, Beil T, Whitlock EP. Screening for preeclampsia:evidence report and systematic review for the USPreventive Services Task Force. JAMA. doi:10.1001/jama. 2016.183157.
7. Huppertz B. Placental origins of preeclampsia:challenging the current hypothesis. Hypertension. 2008;51(4):970-975.
8. Ghulmiyyah L, Sibai B. Maternal mortality frompreeclampsia/eclampsia. Semin Perinatol. 2012;36(1):56-59.
9. LeFevre ML; U. S. Preventive Services Task Force. Low-dose aspirin use for the prevention ofmorbidity and mortality from preeclampsia: U. S. Preventive Services Task Force recommendationstatement. Ann Intern Med. 2014;161(11):819-826.
10. MacKay AP, Berg CJ, Atrash HK. Pregnancy-related mortality from preeclampsia andeclampsia. Obstet Gynecol. 2001;97(4):533-538.
11. TuckerMJ, Berg CJ, CallaghanWM, Hsia J. The black-white disparity in pregnancy-relatedmortality from 5 conditions: Differences in prevalenceand case-fatality rates. AmJ Public Health. 2007;97(2):247-251.
12. Bateman BT, Shaw KM, Kuklina EV, CallaghanWM, Seely EW, Hernández-Diáz S. Hypertension inwomen of reproductive age in the United States:NHANES 1999-2008. PLoS One. 2012;7(4):e36171.
13. Siu AL; U. S. Preventive Services Task Force. Screening for high blood pressure in adults: U. S. Preventive Services Task Force recommendationstatement. Ann Intern Med. 2015;163(10):778-786.
14. Higgins JR, de SwietM. Blood-pressuremeasurement and classification in pregnancy. Lancet. 2001;357(9250):131-135.
15. Pickering TG, Hall JE, Appel LJ, et al. Recommendations for blood pressure measurementin humans and experimental animals: Part 1: Bloodpressure measurement in humans: A statement forprofessionals from the Subcommittee of ProfessionalandPublicEducationoftheAmericanHeartAssociationCouncil on High Blood Pressure Research. Circulation. 2005;111(5):697-716.
16. Meads CA, Cnossen JS, Meher S, et al. Methodsof prediction and prevention of pre-eclampsia:systematic reviews of accuracy and effectivenessliterature with economic modelling. Health TechnolAssess. 2008;12(6):1-270.
17. Siddique J, Lantos JD, VanderWeele TJ, Lauderdale DS. Screening tests during prenatalcare: Does practice follow the evidence? MaternChild Health J. 2012;16(1):51-59.
18. Screening for preeclampsia. In: US PreventiveServices Task Force, eds. Guide to Clinical PreventiveServices:Reportof theUSPreventive ServicesTask Force. 2nd ed. Baltimore, MD: Williams , Wilkins; 1996.
19. Creanga AA, Berg CJ, Ko JY, et al. MaternalmortalityandmorbidityintheUnitedStates:wherearewe now? JWomens Health (Larchmt). 2014;23(1):3-9.
20. Waterstone M, Bewley S, Wolfe C. Incidenceand predictors of severe obstetric morbidity:case-control study. BMJ. 2001;322(7294):1089-1093.
21. Ananth CV, Vintzileos AM. Maternal-fetalconditions necessitating a medical interventionresulting in preterm birth. Am J Obstet Gynecol. 2006;195(6):1557-1563.
22. Lisonkova S, Joseph KS. Incidence ofpreeclampsia: Risk factors and outcomes associatedwith early-versus late-onset disease. Am J ObstetGynecol. 2013;209(6):544. e1-544. e12.
23. McDuffie RS Jr, Beck A, Bischoff K, Cross J, Orleans M. Effect of frequency of prenatal carevisits on perinatal outcome among low-risk women: A randomized controlled trial. JAMA. 1996;275(11):847-851.
24. Altman D, Carroli G, Duley L, et al; Magpie TrialCollaboration Group. Do women withpre-eclampsia, and their babies, benefit frommagnesium sulphate? the Magpie Trial: A randomised placebo-controlled trial. Lancet. 2002;359(9321):1877-1890.
25. Duley L, Gülmezoglu AM, Henderson-Smart DJ, Chou D. Magnesium sulphate and otheranticonvulsants for women with pre-eclampsia. Cochrane Database Syst Rev. 2010;(11):CD000025.
26. Koopmans CM, Bijlenga D, Groen H, et al;HYPITAT Study Group. Induction of labour versusexpectant monitoring for gestational hypertensionor mild pre-eclampsia after 36 weeks' gestation(HYPITAT): A multicentre, open-label randomisedcontrolled trial. Lancet. 2009;374(9694):979-988.
27. Rhode MA, Shapiro H, Jones OWIII. Indicatedvs. routine prenatal urine chemical reagent striptesting. J Reprod Med. 2007;52(3):214-219.
28. Simeone S, Lojo C, Garcia-Esteve L, et al. Psychological impact of first-trimester preventionfor preeclampsia on anxiety. Prenat Diagn. 2015;35(1):60-64.
29. Podymow T, August P. Update on the use ofantihypertensive drugs in pregnancy. Hypertension. 2008;51(4):960-969.
30. Magee LA, Pels A, HelewaM, Rey E, von Dadelszen P; Canadian Hypertensive Disordersof Pregnancy (HDP)Working Group. Diagnosis, evaluation, and management of the hypertensivedisorders of pregnancy. Pregnancy Hypertens. 2014;4(2):105-145.
31. National Institute for Health and Care Excellence. Hypertensioninpregnancy:diagnosisandmanagement. https://www. nice. org. uk/guidance/cg107/chapter/1-Guidance. 2010. Accessed February 28, 2017.
32. American College of Obstetricians andGynecologists. Committee Opinion No. 638:first-trimester risk assessment for early-onsetpreeclampsia. Obstet Gynecol. 2015;126:e25-e27.